Found 94 matching trials
Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia PHASE2 The prognosis for older individuals with acute myelogenous leukemia (AML) h...
Show More Location
University of Michigan Cancer Center
Learn More & Join Trial
Busulfan and Cyclophosphamide Followed By ALLO BMT NA This is a treatment guideline to allow routine clinical data to be collecte...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma PHASE1 Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Show More Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Learn More & Join Trial
ALL-SCT BFM International- HSCT in Children and Adolescents With ALL PHASE3 With this protocol the ALL-SCT BFM international study group wants
* to ev...
Show More Location
Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie
Learn More & Join Trial
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma PHASE1 This research study is assessing the feasibility of reduced intensity allog...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen PHASE3 This study is an extension to younger patients of the currently ongoing nat...
Show More Location
Institut Paoli-Calmettes
Learn More & Join Trial
Administration of Virus-Specific Cytotoxic T-Lymphocytes PHASE1 The main purpose of this study is to see if these T-lymphocytes are safe. T...
Show More Location
National Institute of Health (NIH)
Learn More & Join Trial
Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases PHASE2 This phase II trial investigates how well a naive T cell depleted graft wor...
Show More Location
Seattle Children's Hospital
Learn More & Join Trial
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer PHASE2 RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR PHASE2 The purpose of this study is to determine whether 5-Azacytidine priming bef...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial